Medical Device Rapid Prototyping Services Market Global Report 2026

The medical device rapid prototyping services market size has grown rapidly in recent years. It will grow from $1.88 billion in 2025 to $2.17 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing need to shorten medical device development timelines, growing demand for early design validation, rising complexity of medical device designs, increasing focus on reducing product development risks, and growing outsourcing of prototype development activities.

The medical device rapid prototyping services market size is expected to see rapid growth in the next few years. It will grow to $3.86 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. Growth during the forecast period is expected to be supported by rising demand for faster commercialization of medical devices, increasing adoption of patient-specific device prototyping, growing demand for advanced functional prototypes, wider use of rapid prototyping for manufacturability validation, and increasing demand for outsourced end-to-end prototyping services. Major trends during the forecast period include greater adoption of rapid medical device prototyping, increasing use of three-dimensional printing for medical prototypes, rising demand for functional prototype validation, growing adoption of rapid design iteration, and increasing demand for cost-effective prototype development.

The increasing demand for faster medical device development is expected to propel the growth of the medical device rapid prototyping services market going forward. Medical device development involves designing, testing, validating, and refining medical devices to ensure their safety, effectiveness, functionality, and suitability for clinical use. The increasing demand for faster medical device development is driven by the need for rapid innovation, allowing manufacturers to develop and introduce advanced medical devices more quickly. Medical device rapid prototyping services support faster medical device development by enabling the quick production and evaluation of product prototypes. They help manufacturers identify design issues at an early stage, accelerate product validation, reduce development time and costs, and support faster commercialization. For instance, in March 2026, according to the U.S. Food and Drug Administration (FDA), a US-based federal agency, the Center for Devices and Radiological Health (CDRH) and the Center for Biologics Evaluation and Research (CBER) had granted 1,284 Breakthrough Device designations, including 1,264 by CDRH and 20 by CBER, supporting the acceleration of medical device development. Therefore, the increasing demand for faster medical device development is driving the growth of the medical device rapid prototyping services market.

Major companies operating in the medical device rapid prototyping services market are increasingly prioritizing integrated prototyping hubs and advanced additive manufacturing capabilities to accelerate medical device innovation, enable rapid design iterations, and shorten the development pathway from concepts to validated prototypes. These services integrate virtual and physical prototyping, computer-aided design, modeling, simulation, and 3D printing, allowing developers to identify design issues and validate prototypes more efficiently. For instance, in February 2026, the University of Galway, an Ireland-based public research university, launched a new Medical Device Prototype Hub in partnership with an Ireland-based medical technology company, supported through a five-year €5 million ($5.78 million) innovation partnership focused on MedTech ecosystem development, STEM engagement, and research. The hub provides expert-led concept creation, development, and manufacturing of innovative medical device prototypes, including virtual and physical prototyping, CAD, modeling, simulation, and a one-stop 3D-printing service equipped with advanced additive manufacturing technologies for prototype validation. By combining specialized engineering infrastructure, prototyping expertise, and additive manufacturing, the hub supports faster design iterations and helps accelerate the transition of promising medical technology concepts toward real-world healthcare solutions.

In January 2026, Symmetry Laser, a US-based precision laser cutting solutions company, acquired ArcRev LLC for an undisclosed amount. With this acquisition, Symmetry Laser seeks to strengthen its rapid prototyping and high-volume manufacturing capabilities while expanding its technical expertise, production capacity, and operational scale. The company also aims to accelerate the development of complex medical device components by combining complementary laser cutting technologies, experienced engineering expertise, and lean manufacturing practices. ArcRev LLC is a US-based precision manufacturing company specializing in laser-cut hypotubes, rapid prototyping, and scalable manufacturing solutions for medical device applications.

Major companies operating in the medical device rapid prototyping services market are Stratasys Inc., Protolabs Inc., Materialise NV, Xometry Inc., Formlabs Inc., Fictiv Inc., StarFish Medical, RapidDirect Co. Ltd., Jabil Inc., Flex Ltd., Sanmina Corporation, Plexus Corp., Benchmark Electronics Inc., Creation Technologies International Inc., Avalon Technologies Limited, Stellartech Research Corporation, SyBridge Technologies Inc., Nordson Corporation, TE Connectivity Ltd., StudioRed Inc., Cadence Inc., MW Industries Inc., Remington Medical Inc., EOS GmbH, 3D Systems Corporation, Koch Inc., Westfall Technik Inc.

North America was the dominating region in the medical device rapid prototyping services market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical device rapid prototyping services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical device rapid prototyping services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical device rapid prototyping services market includes revenues earned by entities through prototype validation services, design verification services, prototype optimization services, and prototype documentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

This product will be delivered within 3-5 business days.